Neuroscience Research in Canada
Monday February 13, 2017 from 12:00 p.m. – 1:30 p.m.
Speaker’s Lounge CB-216-N, Centre Block, Parliament Hill, Ottawa, Ontario.
This event is by Invitation only.
To see information and pictures from past events, see the Health Research Caucus section under ‘Advocacy’ in the navigation.
Neuroscience research impacts all Canadians. One in three Canadians will be affected by a neurological disorder, injury or psychiatric disease in their lifetime. For the vast majority of the over thousands of conditions that can affect the nervous system, no clear causes or cures are known. Health Canada has estimated the economic burden of neurological and psychiatric conditions to represent 14% of the total burden of disease in this country, which is more than cardiovascular disease or cancer. This problem will be more and more prevalent as life expectancy is increasing and the population is ageing.
Research Canada, in conjunction with its Member, and the Canadian Association for Neuroscience, will be hosting a luncheon on February 13, 2017 on Parliament Hill for a select group of Parliamentarians that will highlight recent developments which shed new light on the richness of neuroscience research and show great examples of how investments in basic research can and lead to improved treatment strategies for Canadians.
Co-Hosted by 1
The Canadian Association for Neuroscience is a non-profit organization dedicated to the promotion of Neuroscience research in Canada.
CAN-ACN is an Association of researchers, students and trainees actively working in Neuroscience research. Our Association represents the interests of Canadian neuroscientists at national and international levels.
To see more pictures from this event, click on the link here.
Dr. Beverley Orser, MD, PhD, FRCPC
University of Toronto
Dr. Beverley Orser is a clinician-scientist and Professor of Physiology and Anesthesia at the University of Toronto. She is a practicing anesthesiologist and Director of Research, Department of Anesthesia at Sunnybrook Health Science Centre. She will talk about how unveiling the general mechanism by which anaesthetics works can lead to better drug development. She also made very significant contributions to our understanding on how memory is affected by anaesthesia. She is a practicing physician who runs a very successful basic research laboratory.
Dr. Charles Bourque, PhD
McGill University, Montreal
Dr. Bourque is interested in the mechanisms responsible for central detection of circulating sodium, fluid osmolality and core body temperature. His work examines how information detected by thermo- and osmo-sensitive neurons interacts with the brain’s central clock to regulate thirst and vasopressin release. Dr. Bourque’s work also seeks to define how changes in cellular and synaptic properties affect homeostatic function in response to high salt intake and disease states that affect cardiovascular function and/or fluid homeostasis.
Thank you to Our Sponsors
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, oncology and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
At Johnson & Johnson Inc., our mission is to enrich the health and wellness of every Canadian, every day. Behind every one of our brands is a tradition of innovative research, cutting-edge technology, and a deep commitment to delighting our consumers with products that they can trust for their entire family.
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.
Neurological Health Charities Canada (NHCC)
Research and Innovation at McGill University
Institut de Recherches Cliniques de Montréal (IRCM)